The Journal of Clinical Medicine (JCM) has been indexed in Reaxys, a chemistry database. The inclusion underscores the journal’s growing academic influence and highlights the expanding interface between clinical medicine and chemistry. JCM’s extensive clinical research provides vital real-world insights for chemical researchers, and its inclusion in Reaxys means these crucial clinical data will now be deeply integrated with chemical information.
JCM's inclusion in the database will allow researchers worldwide to combine clinical research outcomes with chemical datasets to support drug development and disease analysis. The integration will accelerate target identification, facilitate compound screening, and shorten development timelines.
The availability of clinical data within Reaxys also supports precision medicine by enabling the analysis of toxicological and physicochemical profiles about patient data. This cross-reference aids in refining clinical trial design and tailoring treatment strategies based on molecular characteristics.
Further, access to combined clinical and chemical insights may advance understanding of disease mechanisms at the molecular level, contributing to the development of innovative therapeutic approaches.
Through Reaxys, JCM authors and their findings gain broader international exposure, enhancing the journal’s reach and fostering collaboration across clinical medicine, chemistry, and pharmaceutical research. The indexing also reinforces efforts to build stronger, integrated knowledge platforms across disciplines.
Click here to read the original press release.
